Quality of life measurement of end-stage-renal disease patients in Indonesia based on responses to the EQ-5D-3L questionnaire

The government of Indonesia must tackle the challenge of providing equitable access to dialysis treatment for all patients with end-stage renal disease, if so. the country should exist with strategic policy for providing services that will increase the health-related quality of life for these patients by investigate at their preferred dialysis modality. We, therefore, aimed to study the health dimensions that affect the quality of life in Indonesian patients with end-stage renal disease undergoing hemodialysis or peritoneal dialysis. This cross-sectional study was conducted at three hospitals in Jakarta and Bandung in 2015. In total, 100 patients (50 hemodialysis and 50 peritoneal dialysis) were selected and matched by age, sex, years on dialysis, and diabetes status. Health-related quality of life was assessed by the Indonesian version of the EQ-5D-3L questionnaire, with statistical analysis based on the EQ-5D descriptive system and visual analog scale (EQ-VAS). The analysis based on EQ-5D-3L questionnaire shows that only anxiety/depression dimension which significantly distinguishing the quality of life between the hemodialysis and peritoneal dialysis patients (p < 0.05). For all the dimensions, although the statistical analyses showed no significance differences between the groups based on age and sex, they did show that numerically more patients who underwent peritoneal dialysis felt that they had better health outcomes. Peritoneal dialysis was also associated with greater improvement from dialysis-related complications if patients were younger than 50 years, improved mobility among males, and improved usual activity among females. Anxiety and depression most affected the quality of life of patients, irrespective of whether they received hemodialysis or peritoneal dialysis, indicating that strategies are needed to manage these dimensions better. Moreover, this supports our hypothesis that understanding a patient's values and preferences when choosing dialysis could substantially improve outcomes from end-stage renal disease.